PyInvesting

Market research

ABT Abbott Laboratories

NYSE USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
202B
P/E ratio
37.75
Analyst target
120.2
Dividend yield
2.1%
Beta
0.58

Community

Investor discussion

13 comments

Admin profile picture
Admin

5 years, 4 months ago

Abbott Laboratories is currently in a long term uptrend where the price is trading 4.1% above its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.2.

Abbott Laboratories's total revenue rose by 28.7% to $11B since the same quarter in the previous year.

Its net income has increased by 106.1% to $2B since the same quarter in the previous year.

Finally, its free cash flow grew by 57.4% to $3B since the same quarter in the previous year.

Based on the above factors, Abbott Laboratories gets an overall score of 5/5.

Garry profile picture
Garry

5 years, 7 months ago

$ABT Abbott Receives FDA 510(k) Clearance For The First Rapid Handheld Blood Test For Concussions
Jack Hardy profile picture
Jack Hardy

5 years, 7 months ago

$ABT Earnings report for diagnostic company Novacyt $NVYTF is coming out in a few weeks and it will be HUGE. Black Rock are now the largest shareholder in Novacyt which is about to become a big name in the US market
streamwars profile picture
streamwars

5 years, 7 months ago

$ABT Earnings are 27th Jan I believe...so expect a steady move up to 120 at least before then. Earnings / guidance could be very, very good this time.
TradeWithAlerts profile picture
TradeWithAlerts

5 years, 7 months ago

Large Print $ABT Size: 124442 Price: 110.23 Time: 1604 Amount: $13,717,241.66
Alstomo profile picture
Alstomo

5 years, 7 months ago

$TTOO and $ABT got something up their sleeve 🍿🍿🍿🍿🍿🚀🚀
TCLutz profile picture
TCLutz

5 years, 7 months ago

$ZOM Why Zom ?? $PFE sales team + $ABT sales team launching new product in March of 2021. Will revolutionize the Veterinary Care industry. Jan 4 appointment of CEO Robert (Ref: Multiple companies taken from millions to Billions!) TRUFORMA Commercialization March 2021. 70 Patents. 7 Assays (two new ones added in September 2020). Pending validations and FDA approvals. Qorvo Partnership. Bulk Acoustic Wave (“BAW”) technology. Projected $2.8 billion industry, believed to be the first ever for use at the point-of-care and the first ever available in veterinary medicine. And they just went public 3 years ago. This will be their first major product release. 🔥💀🔥 $BTC.X $DOGE.X
Kenny profile picture
Kenny

5 years, 7 months ago

$XSPA 🚨 anyone Remember $KODK ? 🧐 $2:50 to $60 in 2-3 days when government 🇺🇸 deal 💰? Who’s ready for KODK 2.0 ?? $ABT $MARK $CODX 👀 ✈️ 🧳 🏥✅
BVon profile picture
BVon

5 years, 7 months ago

$ABT I’m just going to post bullish on all of @Thinkingmanstwits picks so everyone thinks I’m smart in a month
Alstomo profile picture
Alstomo

5 years, 8 months ago

$TTOO $ABT Buyout imminent 🚀🚀🚀
TradeWithAlerts profile picture
TradeWithAlerts

5 years, 8 months ago

Large Print $ABT Size: 259701 Price: 107.79 Time: 1900
iello profile picture
iello

5 years, 8 months ago

$XSPA new JetBlue Article $JBLU $$ABT
Paul Meakem profile picture
Paul Meakem

5 years, 8 months ago

$ABT I got into abt feb 110 calls two weaks ago at that solid 106 support, with next earnings end of january (last earnings 10/21/2020), feb calls gives yourself a lot of options and i think they are still dirt cheap at $3.50. Been holding 106 here for 2-3 months. Should retest highs of 114 before next earnings